Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-11

Clinical Trial Update: Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating estrogen replacement therapy in women with early-stage endometrial cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 3 | Status: TERMINATED